ICER releases draft evidence report on treatment for vasomotor symptoms associated with menopause

11 October 2022 - Registration now open for October 19 “Early Insights” webinar. ...

Read more →

Independent review of paracetamol overdose

14 September 2022 - The TGA has published an independent expert report examining the incidence of serious injury and death ...

Read more →

ICER releases draft evidence report on gene therapies for haemophilia A and B

13 September 2022 - Registration now open for 20 September “Early Insights” webinar. ...

Read more →

ICER publishes final evidence report and policy recommendations on treatments for amyotrophic lateral sclerosis

13 September 2022 - Majority of independent appraisal committee voted that evidence is adequate to demonstrate that both AMX0035 and oral ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) - May 2022 meeting

9 September 2022 - The Public Summary Documents (first time rejections and deferrals) from the May 2022 PBAC meeting are now ...

Read more →

Review of Efficient Funding of Chemotherapy Program - interim report

5 September 2022 - The Efficient Funding of Chemotherapy review seeks to investigate current processes involved in the production, distribution ...

Read more →

ACE publishes another tranche of technology guidances (August 2022)

31 August 2022 - Six technology guidance documents were published yesterday. ...

Read more →

ICER publishes evidence report on treatments for obesity management

31 August 2022 - Greater weight loss was seen with semaglutide and with phentermine/topiramate; less weight loss was seen with liraglutide ...

Read more →

PBAC Public Summary Documents – May 2022 meeting

26 August 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2022 PBAC ...

Read more →

2022-2023 cost recovery implementation statement

12 August 2022 - The 2022-23 PBS and NIP cost recovery implementation statement is now available.  ...

Read more →

ICER publishes final evidence report and policy recommendations on beti-cel gene therapy for beta thalassaemia

19 July 2022 - Independent appraisal committee unanimously determined that evidence is adequate to demonstrate that beti-cel provides a net ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) – March 2022 meeting

15 July 2022 - The Public Summary Documents (first time rejections and deferrals) from the March 2022 PBAC meeting are now ...

Read more →

ICER releases draft evidence report on treatments for obesity management

13 July 2022 - Registration now open for 26 July “Early Insights” webinar. ...

Read more →

Drug Utilisation SubCommittee outcome statement

8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available. ...

Read more →

Public Summary Documents – March 2022 PBAC meeting

1 July 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2022 PBAC ...

Read more →